Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tang Ning Tongluo Formula in Type 2 Diabetics
NCT02174042Phase 2Completed
- Sponsor
- Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Start
- Mar 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tangning Tongluo Capsule in type 2 diabetes mellitus (T2DM), sponsored by Guizhou Bailing Group Pharmaceutical Co., Ltd.. Started Mar 2014; status: completed.
02
Drugs
Tangning Tongluo Capsule
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02174042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174042.